Manulife (Manufacturers Life Insurance)’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.61M Sell
263,641
-202,523
-43% -$4.31M 0.01% 1114
2025
Q1
$8.99M Sell
466,164
-10,650
-2% -$205K 0.01% 884
2024
Q4
$8.51M Buy
476,814
+181,185
+61% +$3.23M 0.01% 965
2024
Q3
$6.47M Buy
295,629
+89,572
+43% +$1.96M 0.01% 1101
2024
Q2
$1.61M Buy
206,057
+128,934
+167% +$1.01M ﹤0.01% 1581
2024
Q1
$319K Buy
77,123
+1,043
+1% +$4.32K ﹤0.01% 2364
2023
Q4
$199K Buy
76,080
+8,411
+12% +$22K ﹤0.01% 2632
2023
Q3
$127K Buy
67,669
+21,149
+45% +$39.5K ﹤0.01% 2733
2023
Q2
$117K Buy
+46,520
New +$117K ﹤0.01% 2794